Stanley L. Liauw, Rashmi K. Benda, Christopher G. Morris and Nancy Price Mendenhall Inflammatory breast carcinoma: Outcomes with trimodality therapy for nonmetastatic disease Cancer 100
Version of Record online: 30 JAN 2004 | DOI: 10.1002/cncr.20083
Inflammatory breast carcinoma is an aggressive disease that is treated effectively in select patients by multimodality therapy. Patient outcomes may be improved with therapies that result in better local and systemic control.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field